QuiVad

Home / Sweden / Moberg Pharma AB (publ)

Moberg Pharma AB (publ)

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 2.31% on March 2, 2017. The shaded band matches the twelve months of the first chart.

March 15, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Moberg Pharma AB (publ) by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

125 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 3, 2017Macquarie Funds Management Hong Kong Limited0.96%
April 3, 2017WorldQuant, LLC0.69%
March 31, 2017WorldQuant, LLC0.76%
March 30, 2017WorldQuant, LLC0.76%
March 29, 2017Macquarie Funds Management Hong Kong Limited1.09%
March 28, 2017Macquarie Funds Management Hong Kong Limited1.09%
March 28, 2017WorldQuant, LLC0.88%
March 27, 2017Macquarie Funds Management Hong Kong Limited1.19%
March 27, 2017WorldQuant, LLC0.88%
March 26, 2017Macquarie Funds Management Hong Kong Limited1.19%
March 23, 2017Macquarie Funds Management Hong Kong Limited1.27%
March 22, 2017Macquarie Funds Management Hong Kong Limited1.27%
March 16, 2017Macquarie Funds Management Hong Kong Limited1.39%
March 15, 2017Macquarie Funds Management Hong Kong Limited1.39%
March 3, 2017Macquarie Funds Management Hong Kong Limited1.40%
March 2, 2017Macquarie Funds Management Hong Kong Limited1.40%
March 2, 2017WorldQuant, LLC0.91%
March 1, 2017WorldQuant, LLC0.91%
February 28, 2017Macquarie Funds Management Hong Kong Limited1.33%
February 27, 2017Macquarie Funds Management Hong Kong Limited1.33%
February 24, 2017WorldQuant, LLC0.80%
February 23, 2017Macquarie Funds Management Hong Kong Limited1.20%
February 23, 2017WorldQuant, LLC0.80%
February 22, 2017Macquarie Funds Management Hong Kong Limited1.20%
February 20, 2017WorldQuant, LLC0.74%
February 19, 2017WorldQuant, LLC0.74%
February 16, 2017WorldQuant, LLC0.66%
February 15, 2017WorldQuant, LLC0.66%
February 14, 2017WorldQuant, LLC0.53%
February 13, 2017Macquarie Funds Management Hong Kong Limited1.10%
February 13, 2017WorldQuant, LLC0.53%
February 12, 2017Macquarie Funds Management Hong Kong Limited1.10%
February 7, 2017Macquarie Funds Management Hong Kong Limited1.03%
February 6, 2017Macquarie Funds Management Hong Kong Limited1.03%
February 3, 2017Macquarie Funds Management Hong Kong Limited0.93%
February 2, 2017Macquarie Funds Management Hong Kong Limited0.93%
January 27, 2017Macquarie Funds Management Hong Kong Limited0.80%
January 26, 2017Macquarie Funds Management Hong Kong Limited0.80%
January 20, 2017Macquarie Funds Management Hong Kong Limited0.70%
January 19, 2017Macquarie Funds Management Hong Kong Limited0.70%
January 13, 2017Macquarie Funds Management Hong Kong Limited0.61%
January 12, 2017Macquarie Funds Management Hong Kong Limited0.61%
January 5, 2017Macquarie Funds Management Hong Kong Limited0.50%
January 4, 2017Macquarie Funds Management Hong Kong Limited0.50%
October 19, 2016Macquarie Funds Management Hong Kong Limited0.58%
October 18, 2016Macquarie Funds Management Hong Kong Limited0.61%
October 17, 2016Macquarie Funds Management Hong Kong Limited0.61%
October 12, 2016Macquarie Funds Management Hong Kong Limited0.52%
October 11, 2016Macquarie Funds Management Hong Kong Limited0.52%
August 24, 2016Macquarie Funds Management Hong Kong Limited0.49%

Download 125 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Moberg Pharma AB (publ), source Finansinspektionen, data as at February 12, 2025, https://www.quivad.com/action/moberg-pharma-ab-publ?page=2